Vokes EE - Search Results

1

Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer.

Johnston PG, Mick R, Recant W, Behan KA, Dolan ME, Ratain MJ, Beckmann E, Weichselbaum RR, Allegra CJ, Vokes EE. Johnston PG, et al. Among authors: vokes ee. J Natl Cancer Inst. 1997 Feb 19;89(4):308-13. doi: 10.1093/jnci/89.4.308. J Natl Cancer Inst. 1997. PMID: 9048835

2

Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.

Vokes EE, Weichselbaum RR, Mick R, McEvilly JM, Haraf DJ, Panje WR. Vokes EE, et al. J Natl Cancer Inst. 1992 Jun 3;84(11):877-82. doi: 10.1093/jnci/84.11.877. J Natl Cancer Inst. 1992. PMID: 1375657 Clinical Trial.

3

Suramin: is adaptive control necessary?

Kobayashi K, Vokes EE, Stefansson K, Janisch L, Vogelzang NJ, Berezin F, Ratain MJ. Kobayashi K, et al. Among authors: vokes ee. J Clin Oncol. 1992 Dec;10(12):1984-5; author reply 1985-6. doi: 10.1200/JCO.1992.10.12.1984. J Clin Oncol. 1992. PMID: 1453214 No abstract available.

4

The interaction of 5-fluorouracil, hydroxyurea, and radiation in two human head and neck cancer cell lines.

Vokes EE, Beckett M, Karrison T, Weichselbaum RR. Vokes EE, et al. Oncology. 1992;49(6):454-60. doi: 10.1159/000227092. Oncology. 1992. PMID: 1465284

5

Molecular targets to overcome radioresistance.

Weichselbaum RR, Beckett MA, Hallahan DE, Kufe DW, Vokes EE. Weichselbaum RR, et al. Among authors: vokes ee. Semin Oncol. 1992 Aug;19(4 Suppl 11):14-20. Semin Oncol. 1992. PMID: 1509276 Review.

6

Perspectives on combination chemotherapy with concomitant radiotherapy for poor-prognosis head and neck cancer.

Vokes EE, Haraf DJ, Weichselbaum RR, McEvilly JM, Sutton HG, Panje WR. Vokes EE, et al. Semin Oncol. 1992 Aug;19(4 Suppl 11):47-56. Semin Oncol. 1992. PMID: 1509281

7

Concomitant chemoradiotherapy with cisplatin, 5-fluorouracil and hydroxyurea in poor-prognosis head and neck cancer.

Haraf DJ, Vokes EE, Weichselbaum RR, Panje WR. Haraf DJ, et al. Among authors: vokes ee. Laryngoscope. 1992 Jun;102(6):630-6. doi: 10.1288/00005537-199206000-00007. Laryngoscope. 1992. PMID: 1602911

8

Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: a feasible and active approach.

Vokes EE, Haraf DJ, McEvilly JM, Mick R, Kozloff MF, Goldman MD, Moran WJ, Clendeninn NJ, Collier MA, Weichselbaum RR, et al. Vokes EE, et al. Ann Oncol. 1992 Jan;3(1):79-81. doi: 10.1093/oxfordjournals.annonc.a058079. Ann Oncol. 1992. PMID: 1606074 Clinical Trial.

9

Hydroxyurea with concomitant radiotherapy for locally advanced head and neck cancer.

Vokes EE, Haraf DJ, Panje WR, Schilsky RL, Weichselbaum RR. Vokes EE, et al. Semin Oncol. 1992 Jun;19(3 Suppl 9):53-8. Semin Oncol. 1992. PMID: 1641658

10

Laboratory and clinical studies of biochemical modulation by hydroxyurea.

Schilsky RL, Ratain MJ, Vokes EE, Vogelzang NJ, Anderson J, Peterson BA. Schilsky RL, et al. Among authors: vokes ee. Semin Oncol. 1992 Jun;19(3 Suppl 9):84-9. Semin Oncol. 1992. PMID: 1641659 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

559 results

Search Page